论文部分内容阅读
目的:观察复方玄驹胶囊治疗Ⅲ型前列腺炎的临床疗效。方法:选择符合美国国家卫生研究院(NIH)分类标准,诊断为Ⅲ型前列腺炎的患者242例,随机分为2组对照研究。治疗组121例,应用复方玄驹胶囊治疗,每天3次,每次3粒;辅以盐酸坦索罗辛缓释片,0.2 mg,每天1次。对照组121例,按常规方法治疗,以喹诺酮类抗生素为主,辅以盐酸坦索罗辛缓释片,以及解痉镇痛和镇静催眠剂。分别治疗6周。疗效观察采用NIH-CPSI评分,及相关合并症治疗改善程度情况。结果:242例全部进入评估。6周后治疗组总有效人数为94例,占77.69%(94/121),合并症治疗总有效人数78例,占71.56%(78/109)。对照组总有效人数57例,占47.10%(57/121)。合并症治疗总有效人数34例,占31.78%(34/107),NIH-CPSI评分及相关合并症治疗对比,前者疗效明显优于后者,(P<0.05)。结论:复方玄驹胶囊对Ⅲ型前列腺炎有较好疗效。
Objective: To observe the clinical efficacy of Compound Xuanju Capsule in treating type Ⅲ prostatitis. Methods: A total of 242 patients diagnosed as type Ⅲ prostatitis were selected according to the National Institutes of Health (NIH) classification and were randomly divided into two groups. The treatment group of 121 cases, the application of compound Xuan Ju Capsule treatment, 3 times a day, each 3; supplemented with tamsulosin hydrochloride sustained-release tablets, 0.2 mg, 1 day. The control group of 121 cases, according to the conventional method of treatment, mainly quinolone antibiotics supplemented with tamsulosin hydrochloride sustained-release tablets, as well as antispasmodic analgesic and sedative hypnotic agents. Treatment for 6 weeks. Efficacy observed using NIH-CPSI score, and related complications improve the degree of treatment. Results: All 242 patients were evaluated. After 6 weeks, the total effective number of the treatment group was 94, accounting for 77.69% (94/121). The total number of effective treatment of complications was 78 (71.56%, 78/109). The total effective number of control group 57 cases, accounting for 47.10% (57/121). The total number of effective treatment of complications was 34 (31.78%, 34/107). The NIH-CPSI score and related complications were significantly better than the latter (P <0.05). Conclusion: Compound Xuanju Capsule has a good effect on type Ⅲ prostatitis.